Christoph Schmidt

The oral NK(1) antagonist, aprepitant, given with standard antiemetics provides protection against nausea and vomiting over multiple cycles of cisplatin-based chemotherapy: a combined analysis of two randomised, placebo-controlled phase III clinical trials.

Ronald de Wit, Jørn Herrstedt, Bernardo L. Rapoport et al. · PubMed · 2004 · 146 citations

The oral NK1 antagonist, aprepitant, given with standard antiemetics provides protection against nausea and vomiting over multiple cycles of cisplatin-based chemotherapy

Ronald de Wit, Jørn Herrstedt, Bernardo L. Rapoport et al. · European Journal of Cancer · 2003 · 95 citations

Oral Nk1 Antagonist, Cisplatin-based Chemotherapy, Standard Antiemetics +8

CARMENES: high-resolution spectra and precise radial velocities in the red and infrared

A. Quirrenbach, P. J. Amado, I. Ribas et al. · Ground-based and Airborne Instrumentation for Astronomy VII · 2018 · 75 citations · Full text

Functional relevance of antiemetic control

Amber Martin, A. Carides, Jay D. Pearson et al. · European Journal of Cancer · 2003 · 60 citations

Molecular Pharmacology, Functional Relevance, Medicine +7

Coupled topological interface states

Christoph Schmidt, Alexander Palatnik, M. Sūdžius et al. · Physical review. B./Physical review. B · 2021 · 31 citations

Quantum Science, Photonics, Optical Materials +15